FBIOX — Fidelity Select Biotechnology Portfolio NAV, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Fund facts#
Data provided bySource: Twelve Data- Expense ratio (prospectus)
- 0.62%
- Distribution yield
- Not shown
- YTD total return
- +20.65%
- YTD price return
- +15.76%
- Avg return 3Y
- +27.41%
- Avg return 5Y
- +7.99%
- AUM
- $6.3B (2026-08-31)
- Fund family
- Fidelity
- 52W low
- $24.12
- 52W high
- $31.72
Performance · price returntotal return · as of 2026-11-12#
Data provided bySource: Twelve DataAbout FBIOX#
Objective: “Biotechnology Portfolio seeks capital appreciation.”
How it invests: “Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes , and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based in whole or in part on genetic analysis and genetic engineering.”
Objective and strategy as stated in the fund’s SEC prospectus filing.Official SEC filings ↗
Holdings#
200 holdings · top 10 = 48% · filed Aug 31, 2026Top 10 holdings
Sector weights
Estimated portfolio characteristics
Estimated by our own bottom-up analysis of the fund’s SEC-filed holdings; recomputed daily from public data.
Annualized returns (CAGR)#
Data provided bySource: Twelve DataCompound annual growth rate per holding period, total return (dividends reinvested), from weekly adjusted closes. Each column is anchored at the date under it; horizons the fund’s history can’t span are omitted.
Fund flows#
Net creations minus redemptions per period, from the fund’s SEC Form N-PORT filings (series-level: where a fund shares its portfolio with mutual-fund share classes, flows cover all classes combined). Quarterly filings publish with a ~60-day lag, so recent months appear as filings land. Flow data begins mid-2019 — Form N-PORT did not exist before then, for any fund.